Poniard Pharmaceuticals Inc
Change company Symbol lookup
Select an option...
PARD Poniard Pharmaceuticals Inc
GOLF Acushnet Holdings Corp
AA Alcoa Corp
CNCE Concert Pharmaceuticals Inc
BL Blackline Inc
DFEN Direxion Daily Aerospace & Defense Bull 3X Shares Direxion Daily Aerospace
NVRO Nevro Corp
DBI Designer Brands Inc
UONE Urban One Inc
SONY Sony Group Corp
Go

Health Care : Biotechnology |
Company profile

Poniard Pharmaceuticals, Inc. is a biopharmaceutical company. The Company focuses on the development and commercialization of oncology products to impact the lives of people with cancer. It develops picoplatin, a platinum-based chemotherapeutic agent that is in clinical development for multiple cancer indications, treatment combinations and by two routes of administration. The Company has offices in San Francisco, California; and Seattle, Washington in United States.

Closing Price
$0.00
Day's Change
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--
Day's High
0.00
Day's Low
0.00
Volume
4
  • Prev Close
    0.00
  • Today's Open
    0.00
  • Day's Range
    0.00-0.00
  • Avg Vol (10-day)
    --
  • Last (time)
    3:15p ET 01/04/22
  • Last (size)
    4
  • 52-Wk Range
    0.00 - 0.122
    LowHigh
  • (02/11/21 - 01/04/22)
    0.00%
  • 706.4%
  • Market Cap
    1
  • Shares Outstanding
    1.5M
  • --
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 1.2
  • --
  • --

Latest News

No articles or videos found.

Events

There are no calendar events for PARD.

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.